New Delhi December 20, 2013: Biotechnology major Biocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel therapeutics.
The companies have entered into a licensing and collaboration agreement for the development of a range of siRNA (small interfering RNA) based novel therapeutics,Biocon Ltd said in a statement. Econimic Times
